Ammonium Chloride

DRUG3 trials

Sponsors

Eli Lilly and Company, Yale University, Helsinki University Central Hospital

Conditions

Diuretic ResistanceHealthy SubjectsHeart FailureNon-alcoholic Fatty Liver Disease (NAFLD)

Phase 1

The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects

CompletedNCT01440478

Eli Lilly and CompanyHealthy Subjects

Start: 2011-09-30End: 2011-10-31Target: 30Updated: 2011-10-12

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

RecruitingNCT06209359

Yale UniversityDiuretic Resistance, Heart Failure

Start: 2024-07-24End: 2028-03-01Target: 50Updated: 2024-10-08

Unknown Phase

Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease

Enrolling by invitationNCT06942312

Helsinki University Central HospitalNon-alcoholic Fatty Liver Disease (NAFLD)

Start: 2025-05-01End: 2030-12-31Target: 30Updated: 2025-04-24